Aspen Healthcare acquires Turkish-based VLD Danismanlik
Dubai – Aspen Healthcare, a division of Aspen Pharmacare Holdings Limited, a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets, has acquired Turkish-based VLD Danismanlik.
The agreement was concluded on 25 August 2020 following approval granted by the Turkish Merger Board and provides for VLD Danismanlik to be a subsidiary of Aspen Healthcare and part of Aspen Group.
The acquisition of VLD Danismanlik, Aspen’s partner for regulatory affairs and importation in Turkey, fits into Aspen Healthcare’s strategy to streamline the value chain to be more effective in supplying essential medicines to Turkey and to establish a platform for further expansion in the market.
“Turkey is a strategic and important market for Aspen. We are excited to expand our footprint with our official presence in this country in order to continue our mission of supporting the improved health of patients through the supply of our high quality pharmaceutical products,” said Daniel Vella Friggieri, Aspen Healthcare Regional CEO Middle East, North Africa & Turkey.
Headquartered in Durban, South Africa, Aspen is a leading global specialty and branded multinational pharmaceutical company in both emerging and developed markets.
With an acknowledged presence of more than two decades in the pharmaceutical sector, Aspen improves the health of patients in more than 150 countries through its high quality, affordable and effective healthcare solutions. The Group’s key business segments are Manufacturing and Commercial Pharmaceuticals comprising Regional Brands and Sterile Focus Brands that include Anaesthetics and Thrombosis products.
Aspen employs approximately 10 000 people and has 70 established business operations in 55 countries. The Group operates 23 manufacturing facilities across 15 sites and holds international manufacturing approvals from some of the most stringent global regulatory agencies. Its manufacturing capabilities that are scalable to demand and cover a wide variety of product-types including injectables, oral solid dose, liquids, semi-solids, steriles, biologicals and active pharmaceutical ingredients.
For more information visit www.aspenpharma.com
About VLD Danismanlik
VLD is a Turkish company specialized in regulatory consulting, established in 2009. VLD has worked with several multinational companies and is a subsidiary of Aspen Healthcare since August 2020. VLD ensures the access to the Aspen products in the Turkish market.
For more information, please visit our website: www.aspenpharma.ae